Guidance

Respiratory syncytial virus (RSV) programme: information for healthcare professionals

This guidance is for health practitioners implementing the vaccination programme to protect pregnant women and older adults from RSV.

From:
UK Health Security Agency
Published
12 July 2024
Last updated
18 February 2025 — See all updates

Documents

RSV vaccination of pregnant women for infant protection: information for healthcare practitioners

HTML

RSV vaccination of older adults: information for healthcare practitioners

HTML

Details

The aim of the respiratory syncytial virus (RSV) vaccination programme is to reduce the incidence and severity of RSV disease, and hospitalisation as a result of RSV disease in infants and eligible older adults.

All adults turning 75 years of age on or after 1 September 2024 (born on or after 1 September 1949) should be offered RSV vaccination on or shortly after their 75th birthday.

All pregnant women should be offered the RSV vaccination from week 28 of their pregnancy.

These are year-round, ongoing programmes.

Training on the guidance is available:

Updates to this page

Published 12 July 2024
Last updated 18 February 2025 + show all updates

  1. Both the guidance for the Maternal RSV and Older Adults RSV vaccination programmes have been updated to reflect new data on Guillain-Barré syndrome (GBS) a very rare side effect of the Abrysvo vaccine, updated contraindications and information on vaccination of those under 18 who are pregnant.

  2. First published.

Sign up for emails or print this page

Related content